Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia

NCT00981526 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.

NCT NCT00981526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00981526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
Lead sponsor
University of Massachusetts, Worcester
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
May 31, 2012
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia